Skip to main content
OpenTrials

Clinical trial condition

Pathologic Processes

Explore clinical trials studying Pathologic Processes. Study availability and eligibility vary by location and protocol.

142 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Pathologic Processes trial results

Completed

Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation

NCT04368559

Conditions
Aspergillus, Bacterial Infections and Mycoses, Candidemia, +25 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • UCLA Center for Health Sciences Los Angeles, California, United States
  • Stanford University School of Medicine Stanford, California, United States
  • Augusta University Medical Center Augusta, Georgia, United States
View all 53 locations
View Trial Details
Completed

Defining Causes of Deaths in South and Southeast Asia

NCT04595656

Conditions
Cause of Adult Death, Cause of Child Death, Cause of Maternal Death, +5 more
Locations
  • Building Resources Across Communities (BRAC) Dhaka, Bangladesh
  • villages in Thai-Myanmar border Myawady, Kayin State, Burma
  • Action for Health Development (AHEAD) Battambang, Cambodia
  • Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU) Vientiane, Laos
View Trial Details
Completed

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% in Participants With Alpha1-Antitrypsin Deficiency

NCT04722887

Conditions
Alpha1-Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • University of Florida Gainesville, Florida, United States
  • University of Miami Miami, Florida, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details
Completed

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF)

NCT05938920

Conditions
Fibrosis, Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), +6 more
Locations
  • Anhui Chest Hospital Hefei, Anhui, China
  • The Second Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Peking University Shougang Hospital Beijing, Beijing Municipality, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
View all 22 locations
View Trial Details

Related conditions